WHO naming stem · suffix · 15 listed names
-vudine
This page was written with AI.
uridine derivatives used as antiviral agents and as antineoplastics
Where it sits in a name
WHO writes the stem as -vudine. So the letters vudine sit at the end of the name (…vudine).
All 15 names WHO lists under -vudine
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 4 of 15 names appear in these lists: 4 in the US list (FDA Drugs@FDA) and 4 in the EU central list (EMA); 3 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- alovudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brivudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- censavudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- clevudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- epervudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fosalvudine tidoxilNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fosclevudine alafenamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fozivudine tidoxilNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lamivudinein combination: CIMDUO with tenofovir disoproxil; DELSTRIGO with doravirine + tenofovir disoproxil; DOVATO with dolutegravir; SYMFI with efavirenz + tenofovir disoproxil; TRIUMEQ with abacavir + dolutegravir; TRIUMEQ PD with abacavir + dolutegravir; COMBIVIR (discontinued in FDA listings) with zidovudine; DUTREBIS (discontinued in FDA listings) with raltegravir; EPZICOM (discontinued in FDA listings) with abacavir; SYMFI LO (discontinued in FDA listings) with efavirenz + tenofovir disoproxil; TEMIXYS (discontinued in FDA listings) with tenofovir disoproxil; TRIZIVIR (discontinued in FDA listings) with abacavir + zidovudinein combination: Combivir with zidovudine; Delstrigo with doravirine + tenofovir disoproxil; Dovato with dolutegravir; Kivexa with abacavir; Triumeq with abacavir + dolutegravir; Trizivir with abacavir + zidovudine; Dutrebis (withdrawn) with raltegravir; Lamivudine/Zidovudine Teva (withdrawn) with zidovudine
- netivudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sorivudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- stavudine
- telbivudine
- valnivudineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zidovudineUS brands: RETROVIRin combination: COMBIVIR (discontinued in FDA listings) with lamivudine; TRIZIVIR (discontinued in FDA listings) with abacavir + lamivudineEU (central) brands, in combination: Combivir with lamivudine; Trizivir with abacavir + lamivudine; Lamivudine/Zidovudine Teva (withdrawn) with lamivudine
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Same group, without the stem
WHO also lists this name under -vudine: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. It belongs to the same group of substances as the group (a) names above, yet it does not carry -vudine, so the name alone does not reveal the group.
- edoxudine
Decode another name
Decoded
alovudine
Listed INNCarries the WHO stem -vudine
- -vudineend of the nameWHO lists it hereWHO definition: uridine derivatives used as antiviral agents and as antineoplastics
“alovudine” is an INN that WHO lists under -vudine in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -vudine (Part II B) and the 15 names (Part IV, group (a)), and the 1 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.